Association of nonalcoholic fatty liver disease with insulin resistance -: Is OGTT indicated in nonalcoholic fatty liver disease?

被引:30
作者
Sargin, M
Uygur-Bayramiçli, O
Sargin, H
Orbay, E
Yayla, A
机构
[1] Kartal Educ & Res Hosp, Dept Endocrinol Diabet, Istanbul, Turkey
[2] Kartal Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey
关键词
nonalcoholic fatty liver disease; oral glucose tolerance test; diabetes mellitus;
D O I
10.1097/00004836-200311000-00010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is frequently associated with type 2 diabetes mellitus, obesity, and dyslipidemia. We tested the hypothesis that there may be an association between NAFLD and insulin resistance (IR); and its correlation with glucose tolerance status of subjects who aren't known patients with diabetes. One hundred and seventy-six consecutive patients with elevated serum aminotransferase levels and bright liver were evaluated. Sixty-two patients were excluded from the study. Age, gender, height, weight, body mass index, waist circumferences, and family history of diabetes were recorded. Fasting plasma glucose, insulin, lipid profile were measured. A standard oral glucose tolerance test (OGTT) was performed and the index of IR was calculated according to the HOMA method. Patients with a normal glucose tolerance formed group 1 (64 patients) and patients with impaired or diabetic glucose tolerance group 2 (50 patients). Age, female sex, family history of type 2 diabetes, fasting insulin, fasting plasma glucose and HOMA-R index were statistically significantly different between the groups. Although the subjects in the study are not known patients with diabetes, the prevalence of impaired or diabetic glucose tolerance was prominent. In conclusion, performing OGTT in cases with nonalcoholic fatty liver disease may be useful for early screening of diabetes mellitus.
引用
收藏
页码:399 / 402
页数:4
相关论文
共 26 条
[1]   Management of nonalcoholic steatohepatitis - An analytic review [J].
Agarwal, S ;
Bonkovsky, HL .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (03) :253-261
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[5]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[6]   Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? [J].
Chitturi, S ;
Farrell, G ;
Frost, L ;
Kriketos, A ;
Lin, R ;
Liddle, C ;
Samarasinghe, D ;
George, J .
HEPATOLOGY, 2002, 36 (02) :403-409
[7]   Steatohepatitis: A tale of two "hits"? [J].
Day, CP ;
James, OFW .
GASTROENTEROLOGY, 1998, 114 (04) :842-845
[8]   Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese [J].
Dixon, JB ;
Bhathal, PS ;
O'Brien, PE .
GASTROENTEROLOGY, 2001, 121 (01) :91-100
[9]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[10]  
GOTO T, 1995, INT J OBESITY, V19, P841